These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35134736)

  • 21. COVID-19-associated mucormycosis: Case report and systematic review.
    Dilek A; Ozaras R; Ozkaya S; Sunbul M; Sen EI; Leblebicioglu H
    Travel Med Infect Dis; 2021; 44():102148. PubMed ID: 34454090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review.
    Bhattacharyya A; Sarma P; Sharma DJ; Das KK; Kaur H; Prajapat M; Kumar S; Bansal S; Prakash A; Avti P; Thota P; Reddy DH; Gautam BS; Medhi B
    Indian J Pharmacol; 2021; 53(4):317-327. PubMed ID: 34414911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of COVID 19 Inflammatory Markers in Rhino-Orbito-Cerebral Mucormycosis: A Case Study in Predisposed Patients at a Designated Nodal Centre.
    Goddanti N; Reddy YM; Kumar MK; Rajesh M; Reddy LS
    Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):3498-3504. PubMed ID: 34804904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rhino-orbito-cerebral mucormycosis caused by Rhizopus microsporus var. microsporus in a diabetic patient with COVID-19.
    Munhoz SD; Lellis RF; Reis APC; Del Negro GMB; Sousa MGT; Veasey JV
    An Bras Dermatol; 2022; 97(4):501-504. PubMed ID: 35691738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatal rhino-orbito-cerebral mucormycosis infection associated with diabetic ketoacidosis post-COVID-19.
    Bonates P; João GAP; Cruz KS; Ferreira MS; Baía-da-Silva DC; Farias MEL; Brito-Sousa JD; Santana MF; Oliveira LA; Cortez ACA; Souza JVB; Lacerda MVG
    Rev Soc Bras Med Trop; 2021; 54():e03582021. PubMed ID: 34259759
    [No Abstract]   [Full Text] [Related]  

  • 26. Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes - a tertiary care center experience.
    Soni K; Das A; Sharma V; Goyal A; Choudhury B; Chugh A; Kumar D; Yadav T; Jain V; Agarwal A; Garg M; Bhatnagar K; Elhence P; Bhatia PK; Garg MK; Misra S
    J Mycol Med; 2022 May; 32(2):101238. PubMed ID: 34979299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
    Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
    Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rhino-Orbito-Cerebral Mucormycosis During the Second Wave of Covid-19: The Indian Scenario.
    Bhardwaj R; Sharma A; Parasher A; Gupta H; Sahu S; Pal S
    Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):3492-3497. PubMed ID: 34786356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rise of the phoenix: Mucormycosis in COVID-19 times.
    Ravani SA; Agrawal GA; Leuva PA; Modi PH; Amin KD
    Indian J Ophthalmol; 2021 Jun; 69(6):1563-1568. PubMed ID: 34011742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 Associated Mucormycosis with Newly Diagnosed Diabetes Mellitus in Young Males - A Tertiary Care Experience.
    Kapoor S; Saidha PK; Gupta A; Saini U; Satya S
    Int Arch Otorhinolaryngol; 2022 Jul; 26(3):e470-e477. PubMed ID: 35846801
    [No Abstract]   [Full Text] [Related]  

  • 31. A Novel Study of Correlation of Lipid Parameters with Clinical Profile, Staging and Onset of Rhino Orbito Cerebral Mucormycosis Covid 19 Pandemic.
    V V; St K
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Profile of Patients Admitted With Mucormycosis During the COVID-19 Pandemic in Medicine Emergency of a Tertiary Care Hospital in North India.
    Singla N; Sharma N; Sharma N; Behera A; Bhatia M
    Cureus; 2022 Sep; 14(9):e29219. PubMed ID: 36159346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perioperative anesthesia challenges and outcomes of patients with Rhino-Orbito-Cerebral Mucormycosis during the second wave of COVID-19 pandemic: An observational study.
    Kumari K; Rathod D; Meshram T; Mohammed S; Raju S; Sharma A; Chaudhary B; Bhatia P
    J Anaesthesiol Clin Pharmacol; 2023; 39(4):615-621. PubMed ID: 38269163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperferritinemia and the Extent of Mucormycosis in COVID-19 Patients.
    Bhadania S; Bhalodiya N; Sethi Y; Kaka N; Mishra S; Patel N; Wasim AU; Joshi SS; Shah K
    Cureus; 2021 Dec; 13(12):e20569. PubMed ID: 35103148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The second wave of COVID-19 results in outbreak of mucormycosis: diabetes and immunological perspective.
    Ahirwar AK; Kaim K; Ahirwar P; Kumawat R
    Horm Mol Biol Clin Investig; 2022 Sep; 43(3):353-355. PubMed ID: 34908254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A clinico-pathological study of COVID-19 associated rhino-orbital-cerebral mucormycosis.
    Mani S; Thirunavukkarasu A
    Indian J Ophthalmol; 2022 Mar; 70(3):1013-1018. PubMed ID: 35225563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebrovascular Involvement in Mucormycosis in COVID-19 Pandemic.
    Kulkarni R; Pujari SS; Gupta D; Ojha P; Dhamne M; Bolegave V; Dhonde P; Soni A; Adwani S; Diwan A; Duberkar D; Batra D; Deshpande R; Aurangabadkar K; Palasdeokar N
    J Stroke Cerebrovasc Dis; 2022 Feb; 31(2):106231. PubMed ID: 34890962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current Understanding in the Pathophysiology of SARS-CoV-2-Associated Rhino-Orbito-Cerebral Mucormycosis: A Comprehensive Review.
    Jose A; Singh S; Roychoudhury A; Kholakiya Y; Arya S; Roychoudhury S
    J Maxillofac Oral Surg; 2021 Sep; 20(3):373-380. PubMed ID: 34155426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Code Mucor: Guidelines for the Diagnosis, Staging and Management of Rhino-Orbito-Cerebral Mucormycosis in the Setting of COVID-19.
    Honavar SG
    Indian J Ophthalmol; 2021 Jun; 69(6):1361-1365. PubMed ID: 34011699
    [No Abstract]   [Full Text] [Related]  

  • 40. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
    Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
    Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.